Analyst Price Target is $10.00
▲ +114.13% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Adial Pharmaceuticals in the last 3 months. The average price target is $10.00, with a high forecast of $15.00 and a low forecast of $5.00. The average price target represents a 114.13% upside from the last price of $4.67.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Adial Pharmaceuticals.